Literature DB >> 15713966

Signal in noise: evaluating reported reproducibility of serum proteomic tests for ovarian cancer.

Keith A Baggerly1, Jeffrey S Morris, Sarah R Edmonson, Kevin R Coombes.   

Abstract

Proteomic profiling of serum initially appeared to be dramatically effective for diagnosis of early-stage ovarian cancer, but these results have proven difficult to reproduce. A recent publication reported good classification in one dataset using results from training on a much earlier dataset, but the authors have since reported that they did not perform the analysis as described. We examined the reproducibility of the proteomic patterns across datasets in more detail. Our analysis reveals that the pattern that enabled successful classification is biologically implausible and that the method, properly applied, does not classify the data accurately. We show that the method used in previously published studies does not establish reproducibility and performs no better than chance for classifying the second dataset, in part because the second dataset is easy to classify correctly. We conclude that the reproducibility of the proteomic profiling approach has yet to be established.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15713966     DOI: 10.1093/jnci/dji008

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  59 in total

1.  Opportunities and challenges in omics.

Authors:  Mingming Ning; Eng H Lo
Journal:  Transl Stroke Res       Date:  2010-12-01       Impact factor: 6.829

2.  The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline.

Authors:  Amanda G Paulovich; Jeffrey R Whiteaker; Andrew N Hoofnagle; Pei Wang
Journal:  Proteomics Clin Appl       Date:  2008-10-01       Impact factor: 3.494

3.  Rethinking ovarian cancer: recommendations for improving outcomes.

Authors:  Sebastian Vaughan; Jermaine I Coward; Robert C Bast; Andy Berchuck; Jonathan S Berek; James D Brenton; George Coukos; Christopher C Crum; Ronny Drapkin; Dariush Etemadmoghadam; Michael Friedlander; Hani Gabra; Stan B Kaye; Chris J Lord; Ernst Lengyel; Douglas A Levine; Iain A McNeish; Usha Menon; Gordon B Mills; Kenneth P Nephew; Amit M Oza; Anil K Sood; Euan A Stronach; Henning Walczak; David D Bowtell; Frances R Balkwill
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

4.  Statistical contributions to proteomic research.

Authors:  Jeffrey S Morris; Keith A Baggerly; Howard B Gutstein; Kevin R Coombes
Journal:  Methods Mol Biol       Date:  2010

5.  Screening for ovarian cancer: imaging challenges and opportunities for improvement.

Authors:  K B Mathieu; D G Bedi; S L Thrower; A Qayyum; R C Bast
Journal:  Ultrasound Obstet Gynecol       Date:  2018-03       Impact factor: 7.299

Review 6.  Identifying molecular markers for the early detection of pancreatic neoplasia.

Authors:  Michael Goggins
Journal:  Semin Oncol       Date:  2007-08       Impact factor: 4.929

Review 7.  Transplantation proteomics.

Authors:  Avram Z Traum; Asher D Schachter
Journal:  Pediatr Transplant       Date:  2005-12

Review 8.  Personalized medicine and development of targeted therapies: The upcoming challenge for diagnostic molecular pathology. A review.

Authors:  Manfred Dietel; Christine Sers
Journal:  Virchows Arch       Date:  2006-04-22       Impact factor: 4.064

Review 9.  Quality assessment for clinical proteomics.

Authors:  David L Tabb
Journal:  Clin Biochem       Date:  2012-12-12       Impact factor: 3.281

10.  Proteomic classification of acute leukemias by alignment-based quantitation of LC-MS/MS data sets.

Authors:  Eric J Foss; Dragan Radulovic; Derek L Stirewalt; Jerald Radich; Olga Sala-Torra; Era L Pogosova-Agadjanyan; Shawna M Hengel; Keith R Loeb; H Joachim Deeg; Soheil Meshinchi; David R Goodlett; Antonio Bedalov
Journal:  J Proteome Res       Date:  2012-09-11       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.